High numbers of macrophages, especially M2-like (CD163-positive), correlate with hyaluronan accumulation and poor outcome in breast cancer

Histopathology

Volumn 66, Issue 6, 2015, Pages 873-883

  Tiainen, Satu ^a   Tumelius, Ritva ^b   Rilla, Kirsi ^b   Hämäläinen, Kirsi ^a,b,c   Tammi, Markku ^b   Tammi, Raija ^b   Kosma, Veli Matti ^a,b,c   Oikari, Sanna ^b   Auvinen, Päivi ^a  

^a KUOPIO UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

^c Institute of Clinical Medicine   (Finland)

Author keywords

Breast cancer; CD163; CD68; Hyaluronan; Hyaluronan synthase; Obesity; Tumour associated macrophage

Indexed keywords

CD163 ANTIGEN; CHLORDANE; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; HYALURONIC ACID; PROGESTERONE RECEPTOR; CD68 ANTIGEN, HUMAN; CELL SURFACE RECEPTOR; DIFFERENTIATION ANTIGEN; LEUKOCYTE ANTIGEN;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER STAGING; CANCER SURVIVAL; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; IN SITU HYBRIDIZATION; INFLAMMATION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; TUMOR ASSOCIATED LEUKOCYTE; BREAST TUMOR; COMPLICATION; DISEASE COURSE; FEMALE; KAPLAN MEIER METHOD; MACROPHAGE; METABOLISM; MIDDLE AGED; MORTALITY; OBESITY; PATHOLOGY; PROGNOSIS;

ADULT; AGED; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; BREAST NEOPLASMS; DISEASE PROGRESSION; FEMALE; HUMANS; HYALURONIC ACID; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; KAPLAN-MEIER ESTIMATE; MACROPHAGES; MIDDLE AGED; OBESITY; PROGNOSIS; RECEPTORS, CELL SURFACE;

EID: 84927023965     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/his.12607     Document Type: Article

References (35)

1. Witz IP, Levy-Nissenbaum O. The tumor microenvironment in the post-PAGET era. Cancer Lett. 2006; 242; 1-10.
2. Lewis CE, Leek R, Harris A et al. Cytokine regulation of angiogenesis in breast cancer: the role of tumor-associated macrophages. J. Leukoc. Biol. 1995; 57; 747-751.
3. Mosser DM, Edwards JP. Exploring the full spectrum of macrophage activation. Nat. Rev. Immunol. 2008; 8; 958-969.
4. Murray PJ, Wynn TA. Obstacles and opportunities for understanding macrophage polarization. J. Leukoc. Biol. 2011; 89; 557-563.
5. Allavena P, Sica A, Solinas G et al. The inflammatory micro-environment in tumor progression: the role of tumor-associated macrophages. Crit. Rev. Oncol. Hematol. 2008; 66; 1-9.
6. Mantovani A, Sozzani S, Locati M et al. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol. 2002; 23; 549-555.
7. Hao NB, Lu MH, Fan YH et al. Macrophages in tumor microenvironments and the progression of tumors. Clin. Dev. Immunol. 2012; 2012; 948098.
8. Tang X. Tumor-associated macrophages as potential diagnostic and prognostic biomarkers in breast cancer. Cancer Lett. 2013; 332; 3-10.
9. Lau SK, Chu PG, Weiss LM. CD163: a specific marker of macrophages in paraffin-embedded tissue samples. Am. J. Clin. Pathol. 2004; 122; 794-801.
10. Holness CL, Simmons DL. Molecular cloning of CD68, a human macrophage marker related to lysosomal glycoproteins. Blood 1993; 81; 1607-1613.
11. Gotte M, Yip GW. Heparanase, hyaluronan, and CD44 in cancers: a breast carcinoma perspective. Cancer Res. 2006; 66; 10233-10237.
12. Toole BP. Hyaluronan: from extracellular glue to pericellular cue. Nat. Rev. Cancer 2004; 4; 528-539.
13. Heldin P, Karousou E, Bernert B et al. Importance of hyaluronan-CD44 interactions in inflammation and tumorigenesis. Connect. Tissue Res. 2008; 49; 215-218.
14. Sironen RK, Tammi M, Tammi R et al. Hyaluronan in human malignancies. Exp. Cell Res. 2011; 317; 383-391.
15. Weigel PH, DeAngelis PL. Hyaluronan synthases: a decade-plus of novel glycosyltransferases. J. Biol. Chem. 2007; 282; 36777-36781.
16. Iijima J, Konno K, Itano N. Inflammatory alterations of the extracellular matrix in the tumor microenvironment. Cancers (Basel) 2011; 3; 3189-3205.
17. Toole BP. Hyaluronan-CD44 interactions in cancer: paradoxes and possibilities. Clin. Cancer Res. 2009; 15; 7462-7468.
18. Auvinen P, Tammi R, Parkkinen J et al. Hyaluronan in peritumoral stroma and malignant cells associates with breast cancer spreading and predicts survival. Am. J. Pathol. 2000; 156; 529-536.
19. Auvinen P, Tammi R, Kosma VM et al. Increased hyaluronan content and stromal cell CD44 associate with HER2 positivity and poor prognosis in human breast cancer. Int. J. Cancer 2013; 132; 531-539.
20. Auvinen P, Rilla K, Tumelius R et al. Hyaluronan synthases (HAS1-3) in stromal and malignant cells correlate with breast cancer grade and predict patient survival. Breast Cancer Res. Treat. 2014; 143; 277-286.
21. Lien HC, Lee YH, Jeng YM et al. Differential expression of hyaluronan synthase 2 in breast carcinoma and its biological significance. Histopathology 2014; 65; 328-339.
22. Kobayashi N, Miyoshi S, Mikami T et al. Hyaluronan deficiency in tumor stroma impairs macrophage trafficking and tumor neovascularization. Cancer Res. 2010; 70; 7073-7083.
23. Shabo I, Stal O, Olsson H et al. Breast cancer expression of CD163, a macrophage scavenger receptor, is related to early distant recurrence and reduced patient survival. Int. J. Cancer 2008; 123; 780-786.
24. Tammi R, Pasonen-Seppanen S, Kolehmainen E et al. Hyaluronan synthase induction and hyaluronan accumulation in mouse epidermis following skin injury. J. Invest. Dermatol. 2005; 124; 898-905.
25. Coussens LM, Zitvogel L, Palucka AK. Neutralizing tumor-promoting chronic inflammation: a magic bullet? Science 2013; 339; 286-291.
26. Jokela TA, Kuokkanen J, Karna R et al. Mannose reduces hyaluronan and leukocytes in wound granulation tissue and inhibits migration and hyaluronan-dependent monocyte binding. Wound Repair Regen. 2013; 21; 247-255.
27. Wang A, de la Motte C, Lauer M et al. Hyaluronan matrices in pathobiological processes. FEBS J. 2011; 278; 1412-1418.
28. Meran S, Martin J, Luo DD et al. Interleukin-1beta induces hyaluronan and CD44-dependent cell protrusions that facilitate fibroblast-monocyte binding. Am. J. Pathol. 2013; 182; 2223-2240.
29. de la Motte CA, Hascall VC, Drazba J et al. Mononuclear leukocytes bind to specific hyaluronan structures on colon mucosal smooth muscle cells treated with polyinosinic acid:polycytidylic acid: inter-alpha-trypsin inhibitor is crucial to structure and function. Am. J. Pathol. 2003; 163; 121-133.
30. Kuang DM, Wu Y, Chen N et al. Tumor-derived hyaluronan induces formation of immunosuppressive macrophages through transient early activation of monocytes. Blood 2007; 110; 587-595.
31. van den Brandt PA, Spiegelman D, Yaun SS et al. Pooled analysis of prospective cohort studies on height, weight, and breast cancer risk. Am. J. Epidemiol. 2000; 152; 514-527.
32. Dalamaga M. Obesity, insulin resistance, adipocytokines and breast cancer: new biomarkers and attractive therapeutic targets. World J. Exp. Med. 2013; 3; 34-42.
33. Wellen KE, Hotamisligil GS. Inflammation, stress, and diabetes. J. Clin. Invest. 2005; 115; 1111-1119.
34. Han CY, Subramanian S, Chan CK et al. Adipocyte-derived serum amyloid A3 and hyaluronan play a role in monocyte recruitment and adhesion. Diabetes 2007; 56; 2260-2273.
35. Fjeldborg K, Pedersen SB, Moller HJ et al. Human adipose tissue macrophages are enhanced but changed to an anti-inflammatory profile in obesity. J. Immunol. Res. 2014; 2014; 309548.